0001192482-19-000050.txt : 20190128 0001192482-19-000050.hdr.sgml : 20190128 20190128162002 ACCESSION NUMBER: 0001192482-19-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190124 FILED AS OF DATE: 20190128 DATE AS OF CHANGE: 20190128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sebree Terri B CENTRAL INDEX KEY: 0001297912 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37526 FILM NUMBER: 19545690 MAIL ADDRESS: STREET 1: ZYNERBA PHARMACEUTICALS, INC. STREET 2: 80 W. LANCASTER AVENUE, SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001621443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260389433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 BUSINESS PHONE: 484-581-7505 MAIL ADDRESS: STREET 1: 80 W. LANCASTER AVENUE STREET 2: SUITE 300 CITY: DEVON STATE: PA ZIP: 19333 FORMER COMPANY: FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc. DATE OF NAME CHANGE: 20141003 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-01-24 0001621443 Zynerba Pharmaceuticals, Inc. ZYNE 0001297912 Sebree Terri B C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE, SUITE 300 DEVON PA 19333 0 1 0 0 President Common Stock 2019-01-24 4 A 0 3600 0 A 186146 D Stock Option (right to buy) 3.65 2019-01-24 4 A 0 120000 0 A 2029-01-24 Common Stock 120000 120000 D Shares of restricted stock which vest 50% on the first anniversary of the grant date and 50% on the second anniversary of the grant date, subject to continued employment with the Company. The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company. /s/ Suzanne M. Hanlon, Attorney-in-Fact 2019-01-28